Literature DB >> 15099801

Vascular and cellular responses to pro-inflammatory stimuli in rat dental pulp.

Kátia L M Maltos1, Gustavo B Menezes, Marcelo V Caliari, Orivaldo A Rocha, Júlia M M Santos, Dalton L F Alves, Igor D G Duarte, Janetti N Francischi.   

Abstract

Dental pulp reactivity to various pro-inflammatory stimuli was independently evaluated in rats in terms of a vascular permeability increase and leukocyte recruitment. Substance P, calcitonin-gene related peptide (CGRP) and prostaglandin E(2) (in the picomol range) were applied to the exposed pulp from anesthetised animals and the plasma extravasation measured by the Evans blue content in the tissue following 10 min of administration. Leukocyte recruitment was evaluated morphometrically by counting the cell number present in serial sections of 1:3 4 microm pulp tissue 6 h after bacterial endotoxin (LPS; 0.06-1.2 microg/site) administration. Increase in pulp vascular permeability and cellular recruitment due to the injection of mentioned mediators in the skin or LPS in the peritoneal cavity were used as positive controls. Increase in vascular permeability in the pulp occurred in the same dose-range as observed in the skin, being CGRP the most active substance in both cases. However, it was necessary a higher dose of LPS (1.2 microg) to induce a similar cell recruitment in the pulp as that observed in the rat peritoneal cavity (0.3 microg). These data indicate that dental pulp reactivity presents the same pattern of increase in vascular permeability to other tissues in the rat, being CGRP the most potent mediator in this respect. In addition, they suggest the presence of CGRP receptors in the dental pulp. However, an adequate leukocyte recruitment response to bacterial endotoxin was not mounted, suggesting a deficiency in adhesion molecules in blood vessels in the rat dental pulp.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15099801     DOI: 10.1016/j.archoralbio.2004.01.004

Source DB:  PubMed          Journal:  Arch Oral Biol        ISSN: 0003-9969            Impact factor:   2.633


  10 in total

Review 1.  Calcitonin gene-related peptide antagonists as treatments of migraine and other primary headaches.

Authors:  Peter J Goadsby
Journal:  Drugs       Date:  2005       Impact factor: 9.546

2.  Tissue-selective inflammation in the oral cavity of the rat.

Authors:  Taíssa Iolanda Checón Frade; Diego Carlos Dos Reis; Geovanni Dantas Cassali; Yeshwant S Bakhle; Janetti Nogueira de Francischi
Journal:  Inflammopharmacology       Date:  2016-06-20       Impact factor: 4.473

3.  Effects of ravuconazole treatment on parasite load and immune response in dogs experimentally infected with Trypanosoma cruzi.

Authors:  Lívia de Figueiredo Diniz; Ivo Santana Caldas; Paulo Marcos da Matta Guedes; Geovam Crepalde; Marta de Lana; Cláudia Martins Carneiro; André Talvani; Julio Alberto Urbina; Maria Terezinha Bahia
Journal:  Antimicrob Agents Chemother       Date:  2010-04-19       Impact factor: 5.191

Review 4.  Interplay of Oral, Mandibular, and Facial Disorders and Migraine.

Authors:  Antonia Teruel; Marcela Romero-Reyes
Journal:  Curr Pain Headache Rep       Date:  2022-05-14

5.  Benznidazole therapy during acute phase of Chagas disease reduces parasite load but does not prevent chronic cardiac lesions.

Authors:  Ivo Santana Caldas; André Talvani; Sérgio Caldas; Cláudia Martins Carneiro; Marta de Lana; Paulo Marcos da Matta Guedes; Maria Terezinha Bahia
Journal:  Parasitol Res       Date:  2008-05-04       Impact factor: 2.289

6.  Fexinidazole: a potential new drug candidate for Chagas disease.

Authors:  Maria Terezinha Bahia; Isabel Mayer de Andrade; Tassiane Assíria Fontes Martins; Álvaro Fernando da Silva do Nascimento; Lívia de Figueiredo Diniz; Ivo Santana Caldas; André Talvani; Bernadette Bourdin Trunz; Els Torreele; Isabela Ribeiro
Journal:  PLoS Negl Trop Dis       Date:  2012-11-01

7.  Evaluation of carbon nanotubes functionalized with sodium hyaluronate in the inflammatory processes for oral regenerative medicine applications.

Authors:  Paulo Antônio Martins-Júnior; Marcos Augusto Sá; Alesandra Corte Reis; Celso Martins Queiroz-Junior; Marcelo Vidigal Caliari; Mauro Martins Teixeira; Luiz Orlando Ladeira; Vanessa Pinho; Anderson José Ferreira
Journal:  Clin Oral Investig       Date:  2015-11-10       Impact factor: 3.573

8.  Experimental benznidazole treatment of Trypanosoma cruzi II strains isolated from children of the Jequitinhonha Valley, Minas Gerais, Brazil, with Chagas disease.

Authors:  Jaquelline Carla Valamiel de Oliveira-Silva; Girley Francisco Machado-de-Assis; Maykon Tavares Oliveira; Nívia Carolina Noguieira Paiva; Márcio Sobreira Silva Araújo; Cláudia Martins Carneiro; Olindo Assis Martins-Filho; Helen Rodrigues Martins; Marta de Lana
Journal:  Mem Inst Oswaldo Cruz       Date:  2015-01-23       Impact factor: 2.743

9.  Myenteric plexus is differentially affected by infection with distinct Trypanosoma cruzi strains in Beagle dogs.

Authors:  Nívia Carolina Nogueira-Paiva; Kátia da Silva Fonseca; Paula Melo de Abreu Vieira; Lívia Figueiredo Diniz; Ivo Santana Caldas; Sandra Aparecida Lima de Moura; Vanja Maria Veloso; Paulo Marcos da Matta Guedes; Washington Luiz Tafuri; Maria Terezinha Bahia; Cláudia Martins Carneiro
Journal:  Mem Inst Oswaldo Cruz       Date:  2013-11-04       Impact factor: 2.743

10.  Benznidazole, itraconazole and their combination in the treatment of acute experimental Chagas disease in dogs.

Authors:  Eleonora Lima Alves Cunha; Fernanda Karoline Vieira da Silva Torchelsen; Lucas Maciel Cunha; Maykon Tavares Oliveira; Levi Eduardo Soares Reis; Kátia da Silva Fonseca; Paula Melo Abreu Vieira; Cláudia Martins Carneiro; Marta Lana
Journal:  MethodsX       Date:  2019-10-21
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.